{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T17:12:58Z","timestamp":1777914778280,"version":"3.51.4"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hepatocellular carcinoma (HCC) is a major complication of chronic hepatitis C virus (HCV) infection, and its early diagnosis is limited by the suboptimal performance of \u03b1-fetoprotein. Circulating microRNAs (miRNAs) have emerged as promising noninvasive biomarkers for detecting malignant transformation in high-risk patients. This study evaluated the diagnostic value of serum miRNA-141.3p, miRNA-155, miRNA-106b, and miRNA-423 in distinguishing HCC from liver cirrhosis among HCV-infected individuals and developed a combined miRNA-based predictive score.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 145 participants were included: 42 patients with HCV-related HCC, 83 cirrhotic HCV patients without malignancy, and 20 healthy controls. Serum miRNA levels were quantified. Diagnostic performance was assessed by receiver operating characteristic curve analysis, and multivariate discriminant analysis was used to construct a composite index, termed the miR-HCC Detect score.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      All four miRNAs were significantly upregulated in cirrhosis and HCC compared with healthy controls (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05), with the highest expression observed in HCC. Individually, miRNA-155 and miRNA-141.3p demonstrated strong diagnostic accuracy for differentiating HCC from controls [area under the curve (AUC) = 0.988 and 0.924, respectively], while miRNA-106b and miRNA-423 showed moderate discrimination between HCC and cirrhosis. The miR-HCC Detect score achieved an AUC of 0.824, with 96% sensitivity and 62% specificity at a cutoff value of 0.44, and clearly differentiated cirrhosis from HCC (0.63 \u00b1 0.16 vs. 5.1 \u00b1 1.67;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>These circulating miRNAs represent promising noninvasive biomarkers for HCC detection in HCV-infected patients. The miR-HCC Detect score outperforms individual miRNAs and may improve early HCC surveillance.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/meg.0000000000003145","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T20:01:24Z","timestamp":1769630484000},"page":"625-631","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["MicroRNA hepatocellular carcinoma detect: discriminant function based on a circulating panel of microRNA for accurate diagnosis of hepatocellular carcinoma patients on top hepatitis C virus infection"],"prefix":"10.1097","volume":"38","author":[{"given":"Hani","family":"Saleh","sequence":"first","affiliation":[{"name":"Cancer Biology Research Unit"},{"name":"Chemistry Department, Faculty of Science, Capital University, Cairo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hatem","family":"El-mezayen","sequence":"additional","affiliation":[{"name":"Cancer Biology Research Unit"},{"name":"Chemistry Department, Faculty of Science, Capital University, Cairo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aml","family":"El-Sharkawy","sequence":"additional","affiliation":[{"name":"Damietta Cancer Institute, Clinical Pathology Department, Damietta, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Mounir","sequence":"additional","affiliation":[{"name":"Cancer Biology Research Unit"},{"name":"Chemistry Department, Faculty of Science, Capital University, Cairo"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2026,1,22]]},"reference":[{"key":"R1-20260501","doi-asserted-by":"crossref","first-page":"100532","DOI":"10.1016\/j.clinme.2025.100532","article-title":"Hepatocellular carcinoma (HCC): an update on risk factors, surveillance, diagnosis and treatment strategies.","volume":"25","author":"Mathew","year":"2025","journal-title":"Clin Med (Lond)"},{"key":"R2-20260501","doi-asserted-by":"crossref","first-page":"57","DOI":"10.5005\/jp-journals-10018-1260","article-title":"Epidemiology, genotype distribution, prognosis, control, and management of viral hepatitis B, C, D, and hepatocellular carcinoma in Mongolia.","volume":"8","author":"Baatarkhuu","year":"2018","journal-title":"Euroasian J Hepatogastroenterol"},{"key":"R3-20260501","doi-asserted-by":"crossref","first-page":"e2400592","DOI":"10.1200\/GO-24-00592","article-title":"Pragmatic approach to hepatocellular carcinoma diagnosis in high-incidence, resource-limited settings in Africa.","volume":"11","author":"Kirk","year":"2025","journal-title":"JCO Glob Oncol"},{"key":"R4-20260501","first-page":"498","article-title":"Advances in the treatment of hepatocellular carcinoma: an overview of the current and evolving therapeutic landscape for clinicians.","volume":"75","author":"Moris","year":"2025","journal-title":"CA Cancer J Clin"},{"key":"R5-20260501","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.hpb.2025.08.011","article-title":"Establishing alpha-fetoprotein reference ranges in patients with chronic liver disease and hepatocellular carcinoma.","volume":"27","author":"Kalyuzhnyy","year":"2025","journal-title":"HPB (Oxford)"},{"key":"R6-20260501","doi-asserted-by":"crossref","first-page":"413","DOI":"10.2147\/JHC.S272762","article-title":"Serum tumor markers for early diagnosis of primary hepatocellular carcinoma.","volume":"7","author":"Zong","year":"2020","journal-title":"J Hepatocell Carcinoma"},{"key":"R7-20260501","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1016\/j.ejca.2012.02.065","article-title":"Predictive value of alpha-fetoprotein in the long-term risk of developing hepatocellular carcinoma in patients with hepatitis B virus infection \u2013 results from a clinic-based longitudinal cohort.","volume":"48","author":"Hann","year":"2012","journal-title":"Eur J Cancer"},{"key":"R8-20260501","article-title":"Severe Rhodococcus equi pneumonia following hepatic arterial infusion chemotherapy combined with sintilimab and lenvatinib in hepatocellular carcinoma: a case report.","volume":"25","author":"Luo","year":"2025","journal-title":"BMC Infect Dis"},{"key":"R9-20260501","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s10238-025-01877-8","article-title":"Sustained AFP-L3 or DCP expression is associated with progression risk and inferior outcomes in unresectable hepatocellular carcinoma.","volume":"25","author":"Nunez","year":"2025","journal-title":"Clin Exp Med"},{"key":"R10-20260501","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.jpha.2022.11.001","article-title":"Corrigendum to \u2018The potential of miRNA-based therapeutics in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a review\u2019 [J. Pharma. Anal. 11 (2021) 265-271].","volume":"12","author":"Dwi Rizkita","year":"2022","journal-title":"J Pharm Anal"},{"key":"R11-20260501","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1038\/leu.2012.106","article-title":"Impact of serum storage conditions on microRNA stability.","volume":"26","author":"Grasedieck","year":"2012","journal-title":"Leukemia"},{"key":"R12-20260501","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/lipd.12144","article-title":"Identification of suitable reference genes for quantitative gene expression analysis in innervated and denervated adipose tissue from cafeteria diet-fed rats.","volume":"54","author":"Marques-Oliveira","year":"2019","journal-title":"Lipids"},{"key":"R13-20260501","doi-asserted-by":"crossref","first-page":"e39489","DOI":"10.1016\/j.heliyon.2024.e39489","article-title":"Deciphering the multifaceted role of microRNAs in hepatocellular carcinoma: integrating literature review and bioinformatics analysis for therapeutic insights.","volume":"10","author":"Rahdan","year":"2024","journal-title":"Heliyon"},{"key":"R14-20260501","doi-asserted-by":"crossref","first-page":"e0118825","DOI":"10.1128\/spectrum.01188-25","article-title":"Identification of intratumoral bacteria correlated with hepatitis B virus (HBV) levels: a prognostic indicator for patient outcomes in hepatocellular carcinoma patients.","volume":"13","author":"Dang","year":"2025","journal-title":"Microbiol Spectr"},{"key":"R15-20260501","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.ejso.2005.04.008","article-title":"Comparison between the fifth and sixth editions of the AJCC\/UICC TNM staging systems for hepatocellular carcinoma: multicentric study on 393 cirrhotic resected patients.","volume":"31","author":"Varotti","year":"2005","journal-title":"Eur J Surg Oncol"},{"key":"R16-20260501","doi-asserted-by":"crossref","first-page":"291","DOI":"10.52547\/ibj.3594","article-title":"MiR-106b-5p regulates the reprogramming of spermatogonial stem cells into iPSC (induced pluripotent stem cell)-like cells.","volume":"26","author":"Hasani Fard","year":"2022","journal-title":"Iran Biomed J"},{"key":"R17-20260501","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/FM9.0000000000000169","article-title":"miRNA-141-5p affects the levels of neutrophil elastase in preeclampsia by regulating MAPK1.","volume":"4","author":"Cheng","year":"2022","journal-title":"Matern Fetal Med"},{"key":"R18-20260501","first-page":"3239","article-title":"miRNA-155 expression and role in pathogenesis in spinal tuberculosis-induced intervertebral disc destruction.","volume":"17","author":"Yang","year":"2019","journal-title":"Exp Ther Med"},{"key":"R19-20260501","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/s13046-025-03524-2","article-title":"MiR-423-5p is a metabolic and growth tuner in hepatocellular carcinoma via MALAT-1 and mitochondrial interaction.","volume":"44","author":"Bocchetti","year":"2025","journal-title":"J Exp Clin Cancer Res"},{"key":"R20-20260501","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.3892\/ijmm.2015.2338","article-title":"Differential distribution of U6 (RNU6-1) expression in human carcinoma tissues demonstrates the requirement for caution in the internal control gene selection for microRNA quantification.","volume":"36","author":"Lou","year":"2015","journal-title":"Int J Mol Med"},{"key":"R21-20260501","first-page":"43","article-title":"Risk factors for developing hepatocellular carcinoma in Egypt.","volume":"2","author":"Omar","year":"2013","journal-title":"Chin Clin Oncol"},{"key":"R22-20260501","doi-asserted-by":"crossref","first-page":"39431","DOI":"10.1038\/s41598-025-22927-x","article-title":"Minimal clinical predictors enable machine learning detection of hepatocellular carcinoma in a Filipino cohort.","volume":"15","author":"Roxas-Villanueva","year":"2025","journal-title":"Sci Rep"},{"key":"R23-20260501","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.3390\/nu13072245","article-title":"The role of miR-155 in nutrition: modulating cancer-associated inflammation.","volume":"13","author":"Zanoaga","year":"2021","journal-title":"Nutrients"},{"key":"R24-20260501","first-page":"19","article-title":"An overview of epithelial-to-mesenchymal transition and mesenchymal-to-epithelial transition in canine tumors: how far have we come?","volume":"10","author":"Armando","year":"2022","journal-title":"Vet Sci"},{"key":"R25-20260501","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.3390\/biomedicines13092243","article-title":"MicroRNA landscape in hepatocellular carcinoma: metabolic re-wiring, predictive and diagnostic biomarkers, and emerging therapeutic targets.","volume":"13","author":"Liapopoulos","year":"2025","journal-title":"Biomedicines"}],"container-title":["European Journal of Gastroenterology &amp; Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MEG.0000000000003145","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T17:01:16Z","timestamp":1777654876000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MEG.0000000000003145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,22]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/meg.0000000000003145","relation":{},"ISSN":["0954-691X","1473-5687"],"issn-type":[{"value":"0954-691X","type":"print"},{"value":"1473-5687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,22]]},"assertion":[{"value":"2025-12-19","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-08","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}